Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4846819, 10 pages
http://dx.doi.org/10.1155/2016/4846819
Research Article

Exogenous Angiotensin I Metabolism in Aorta Isolated from Streptozotocin Treated Diabetic Rats

1Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland
2Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland
3Department of Pharmacology, Medical Faculty, University of Rzeszów, Rzeszów, Poland

Received 1 July 2016; Accepted 31 August 2016

Academic Editor: Raffaele Marfella

Copyright © 2016 P. P. Wołkow et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Cooper, “The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications,” American Journal of Hypertension, vol. 17, supplement 2, pp. 16S–20S, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Pernomian, L. Pernomian, and C. B. A. Restini, “Counter-regulatory effects played by the ACE—Ang II—AT1 and ACE2—Ang-(1-7)—Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications,” Vasa, vol. 43, no. 6, pp. 404–414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Vauquelin, Y. Michotte, I. Smolders et al., “Cellular targets for angiotensin II fragments: pharmacological and molecular evidence,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 3, no. 4, pp. 195–204, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Elsner, B. Guldbakke, M. Tiedge, R. Munday, and S. Lenzen, “Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin,” Diabetologia, vol. 43, no. 12, pp. 1528–1533, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Romero-Nava, J. E. Rodriguez, A. A. Reséndiz-Albor et al., “Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats,” Clinical and Experimental Hypertension, vol. 38, no. 1, pp. 56–62, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Campbell, D. J. Kelly, J. L. Wilkinson-Berka, M. E. Cooper, and S. L. Skinner, “Increased bradykinin and ‘normal’ angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats,” Kidney International, vol. 56, no. 1, pp. 211–221, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Van Linthout, F. Spillmann, M. Lorenz et al., “Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor,” Hypertension, vol. 53, no. 4, pp. 682–687, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Failli, C. Alfarano, S. Franchi-Micheli et al., “Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats,” Cardiovascular Diabetology, vol. 8, article 32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. A. Fraga-Silva, F. P. Costa-Fraga, T. M. Murça et al., “Angiotensin-converting enzyme 2 activation improves endothelial function,” Hypertension, vol. 61, no. 6, pp. 1233–1238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Bujak-Gizycka, J. Madej, P. P. Wołkow et al., “Measurement of angiotensin metabolites in organ bath and cell culture experiments by Liquid Chromatography - Electrospray Ionization—Mass Spectrometry (LC-ESI-MS),” Journal of Physiology and Pharmacology, vol. 58, no. 3, pp. 529–540, 2007. View at Google Scholar · View at Scopus
  11. R. Olszanecki, B. Bujak-Gizycka, J. Madej et al., “Kaempferol, but not resveratrol inhibits angiotensin converting enzyme,” Journal of Physiology and Pharmacology, vol. 59, no. 2, pp. 387–392, 2008. View at Google Scholar · View at Scopus
  12. A. M. Ladeia, R. R. Sampaio, M. C. Hita, and L. F. Adan, “Prognostic value of endothelial dysfunction in type 1 diabetes mellitus,” World Journal of Diabetes, vol. 5, no. 5, pp. 601–605, 2014. View at Publisher · View at Google Scholar
  13. R. McFarlane, R. J. McCredie, M.-A. Bonney et al., “Angiotensin converting enzyme inhibition and arterial endothelial function in adults with Type 1 diabetes mellitus,” Diabetic Medicine, vol. 16, no. 1, pp. 62–66, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. R. E. Maser and M. J. Lenhard, “Effect of treatment with losartan on cardiovascular autonomic and large sensory nerve fiber function in individuals with diabetes mellitus: a 1-year randomized, controlled trial,” Journal of Diabetes and its Complications, vol. 17, no. 5, pp. 286–291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Müller, P. Fasching, R. Schmid, T. Burgdorff, W. Waldhäusl, and H. G. Eichler, “Inhibition of paracrine angiotensin-converting enzyme in vivo: effects on interstitial glucose and lactate concentrations in human skeletal muscle,” European Journal of Clinical Investigation, vol. 27, no. 10, pp. 825–830, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Lupi, S. Del Guerra, M. Bugliani et al., “The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets,” European Journal of Endocrinology, vol. 154, no. 2, pp. 355–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Furuhashi, N. Ura, H. Takizawa et al., “Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity,” Journal of Hypertension, vol. 22, no. 10, pp. 1977–1982, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Frossard, C. Joukhadar, G. Steffen, R. Schmid, H. G. Eichler, and M. Müller, “Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II- receptor-inhibition on transcapillary glucose transport in humans,” Life Sciences, vol. 66, no. 10, pp. PL147–PL154, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Folli, M. J. A. Saad, L. Velloso et al., “Crosstalk between insulin and angiotensin II signalling systems,” Experimental and Clinical Endocrinology and Diabetes, vol. 107, no. 2, pp. 133–139, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. K. B. Brosnihan, P. Li, and C. M. Ferrario, “Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide,” Hypertension, vol. 27, no. 3, pp. 523–528, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kahraman, C. Aydin, G. O. Elpek, E. Dirice, and A. D. Sanlioglu, “Diabetes-resistant NOR mice are more severely affected by streptozotocin compared to the diabetes-prone NOD Mice: correlations with liver and kidney GLUT2 Expressions,” Journal of Diabetes Research, vol. 2015, Article ID 450128, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. Head, P. A. Longhurst, R. L. Panek, and R. E. Stitzel, “A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit,” British Journal of Pharmacology, vol. 91, no. 2, pp. 275–286, 1987. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Hong and S. Villafaña, “Early diabetes in WKY and SHR produces decrease of the responses to angiotensin II and 5-HT and changes in the NO-GMPc pathway,” Clinical and Experimental Hypertension, vol. 31, no. 5, pp. 462–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. H. S. Arun, C. L. Kaul, and P. Ramarao, “High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta,” Pharmacological Research, vol. 50, no. 6, pp. 561–568, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Crespo and D. C. Dunbar, “Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats,” Cellular and Molecular Biology, vol. 49, no. 8, pp. 1311–1318, 2003. View at Google Scholar · View at Scopus
  26. F. Fiordaliso, I. Cuccovillo, R. Bianchi et al., “Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes,” Life Sciences, vol. 79, no. 2, pp. 121–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Mahmood, H. L. Jackman, L. Teplitz, and R. Igić, “Metabolism of angiotensin I in the coronary circulation of normal and diabetic rats,” Peptides, vol. 23, no. 6, pp. 1171–1175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Verma, Z. Shan, B. Lei et al., “ACE2 and Ang-(1–7) confer protection against development of diabetic retinopathy,” Molecular Therapy, vol. 20, no. 1, pp. 28–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. V. B. Patel, N. Parajuli, and G. Y. Oudit, “Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications,” Clinical Science, vol. 126, no. 7, pp. 471–482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Vinh, R. E. Widdop, G. R. Drummond, and T. A. Gaspari, “Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice,” Cardiovascular Research, vol. 77, no. 1, pp. 178–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Vinh, R. E. Widdop, S. Y. Chai, and T. A. Gaspari, “Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma,” Atherosclerosis, vol. 200, no. 1, pp. 37–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Nasser, N. Clere, L. Botelle et al., “Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice,” Cardiovascular Diabetology, vol. 13, article 40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. S. Karnik, H. Unal, J. R. Kemp et al., “Angiotensin receptors: Interpreters of pathophysiological angiotensinergic stimulis,” Pharmacological Reviews, vol. 67, no. 4, pp. 754–819, 2015. View at Publisher · View at Google Scholar · View at Scopus